title: [What to do with a rising PSA after complete remission post-prostatectomy?].
abstract: Between twenty and to forty percent of patients will develop an isolated PSA failure after a radical prostatectomy. Pelvic irradiation is a therapeutic option with curative intention. It is the best therapeutic option for young people with good prognostic factors. Combined radiation with hormonal or chemotherapy should be evaluated in patients with poor prognostic factors. For patients with a short life expectancy, hormonotherapy or a watch and see policy are acceptable options.
authors.affiliation: Service de Radiothérapie, Centre Georges-François-Leclerc, 1, rue du Professeur-Marion, BP 77980, 21079 Dijon cedex, France. mathieu.bosset@wanadoo.fr
authors.forename: M
authors.initials: M
authors.lastname: Bosset
authors.forename: J-F
authors.initials: JF
authors.lastname: Bosset
authors.forename: P
authors.initials: P
authors.lastname: Maingon
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood / Q000601:surgery*; D018714:Radiotherapy, Adjuvant; D012074:Remission Induction
chemical_list: D018931:Antineoplastic Agents, Hormonal; D017430:Prostate-Specific Antigen